Pharmascience Inc. Sustainability Profile
Pharmascience Inc., a leading player in the pharmaceutical industry, is headquartered in California and operates extensively across North America and beyond. Founded in 2003, the company has established itself as a trusted provider of high-quality generic medications and innovative healthcare solutions. Pharmascience's core offerings include a diverse range of prescription and over-the-counter products, distinguished by their commitment to safety, efficacy, and affordability. The company has achieved significant milestones, including numerous regulatory approvals and partnerships that enhance its market presence. With a strong focus on research and development, Pharmascience Inc. continues to advance its product portfolio, positioning itself as a key contributor to the global healthcare landscape. Its dedication to quality and patient care has earned it a reputable standing in the competitive pharmaceutical market.
DitchCarbon Score
How does Pharmascience Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pharmascience Inc.'s score of 26 is lower than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Pharmascience Inc.'s reported carbon emissions
Pharmascience Inc., headquartered in California, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. As a current subsidiary, Pharmascience Inc. may inherit climate commitments and data from its parent organisation; however, no specific details regarding such cascaded information are available. The company appears to be in the early stages of establishing its climate strategy and emissions reporting framework. In the broader context of the pharmaceutical industry, companies are increasingly focusing on sustainability and carbon reduction initiatives. Pharmascience Inc. will need to align with these industry standards to enhance its environmental performance and transparency in the future.
How Carbon Intensive is Pharmascience Inc.'s Industry?
How Carbon Intensive is Pharmascience Inc.'s Location?
Pharmascience Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Pharmascience Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
